Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES

PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE

Standard Dose
120MG;5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES is listed in Drugs@FDA under application 072758 (ANDA).

Marketing status: Discontinued Active ingredient PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 120MG;5MG Sponsor KV PHARM Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES is listed in Drugs@FDA under application 072758 (ANDA). Marketing status: Discontinued Active ingredient PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - 120MG;5MG Sponsor KV PHARM Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES (PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline